Cell culture systems that allow you to grow cells under more physiologically relevant conditions is emerging as the new golden standard for cell-based research, therapy and drug discovery.

BioLamina offers an expansive portfolio of defined and xeno-free hrLaminin cell culture matrices for a variety of cellular applications, including reliable expansion of hPSCs and differentiation and maintenance of specialized cell types. 
BIORELEVANT CELL MODELS
RECENT SCIENTIFIC BREAKTHROUGHS
 
DOPAMINERGIC NEURONS
High yield of clinically compliant dopaminergic neurons
 
HEPATOCYTES
Functional organization of hPSC-derived and primary hepatocytes 
  
RPE CELLS
Clinically compliant hESC-derived retinal pigmented epithelial cells 


MYOBLASTS
Maintained differentiation potential of satellite cell-derived myoblasts during long-term culture
 

MORE APPLICATIONS HERE 
ON-DEMAND WEBINARS 
Have a look at the webinar collection below to see how researchers are using hrLaminin cell culture substrates and how they contribute to their scientific success.
01.Luigi Warren
 
 Messenger RNA reprogramming and the path to clinically relevant iPSCs
 
Luigi Warren, PhD
CEO, Cellular Reprogramming, Inc, USA
06.Agnete Kirkeby
 Efficient production of hESC-derived dopaminergic progenitors under GMP conditions for treatment of Parkinson’s Disease

Agnete Kirkeby, PhD
PostDoc, Lund University, Sweden
05.Kate Cameron
 
 Defined and scalable generation of hepatocyte-like cells from hPSCs

Kate Cameron, PhD
PostDoc, University of Edinburgh, UK
BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine & Cell-Based Assays Part V
 Pancreas specific laminins enable expansion and maintenance of pancreatic islets in vitro 
 
Anna Domogatskaya, PhD
Sr. Researcher, Karolinska Institute, Sweden
 
02.Anna Falk
 iPSC-derived cellular models to study the cellular mechanisms behind neurodevelopmental disorders 

Anna Falk, PhD
Ass. Prof., Karolinska Institute, Sweden
BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine & Cell-Based Assay Part III
 Clonal derivation and long-term expansion of hPSCs under defined and xeno-free conditions

Sergey Rodin, PhD
Sr. Researcher, Karolinska Institute, Sweden
BioLamina Symposium 2014 Biorelevant Approaches to Regenerative Medicine & Cell-Based Assays Part IV

 Embryonic stem cell-based therapy for advanced macular degeneration

Sonya Stenfelt, PhD
PostDoc, Karolinska Institute, Sweden
Do you want to test the hrLaminin in your research?
Request a free sample HERE
Visit our science room for more information about our human recombinant laminin cell culture substrates. Please do not hesitate to contact me for more information about our products and how we can help you with your hPSC research. 
Kind regards,
LOUISE HAGBARD, PhD
Marketing & Application Manager
Mobile: +46-70-864 2664
Email: louise.hagbard@biolamina.com
Web: www.biolamina.com

Copyright © 2017 BioLamina, All rights reserved.
You are receiving this email because you have opted in either in person, at our website or by email.

Limit of one sample per kit, for any new user or laboratory in an applicable country. Other conditions or restrictions may apply.

Our mailing address is:
BioLamina
Löfströms allé 5A
17266 Sundbyberg 
Sweden

Add us to your address book

Unsubscribe from this list    Update subscription preferences 
 
LinkedIn
Twitter
Facebook
Website